β-Ecdysterone Protects SH-SY5Y Cells Against 6-Hydroxydopamine-Induced Apoptosis via Mitochondria-Dependent Mechanism: Involvement of p38MAPK–p53 Signaling Pathway

Mitochondrial dysfunction in Parkinson's disease

Winklhofer, K. F., & Haass, C. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.08.013 · Cited by 688 · see citing works

Mitochondrial Dysfunction in Parkinson’s Disease

Moon, H. E., & Paek, S. H. (2015) · Experimental Neurobiology · doi:10.5607/en.2015.24.2.103 · Cited by 455 · see citing works

Regulation of the Intrinsic Apoptosis Pathway by Reactive Oxygen Species

Wu, C.-C., & Bratton, S. B. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.4905 · Cited by 410 · see citing works

Activation of Apoptosis Signal-regulating Kinase 1 by Reactive Oxygen Species through Dephosphorylation at Serine 967 and 14-3-3 Dissociation

Goldman, E. H., Chen, L., & Fu, H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311129200 · Cited by 221 · see citing works

Analysis of rpoS and bolA gene expression under various stress-induced environments in planktonic and biofilm phase using 2−ΔΔCT method

Adnan, M., Morton, G., & Hadi, S. S. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-011-0898-y · Cited by 204 · see citing works

Oxidative Stress-Induced Signaling Pathways Implicated in the Pathogenesis of Parkinson’s Disease

Gaki, G. S., & Papavassiliou, A. G. (2014) · NeuroMolecular Medicine · doi:10.1007/s12017-014-8294-x · Cited by 200 · see citing works

The impact of reactive oxygen species and genetic mitochondrial mutations in Parkinson's disease

Zuo, L., & Motherwell, M. S. (2013) · Gene · doi:10.1016/j.gene.2013.07.085 · Cited by 194 · see citing works

Inflammatory outcomes of apoptosis, necrosis and necroptosis

Davidovich, P. B., Kearney, C. J., & Martin, S. J. (2014) · Biological Chemistry · doi:10.1515/hsz-2014-0164 · Cited by 187 · see citing works

T1‐Weighted MRI shows stage‐dependent substantia nigra signal loss in Parkinson's disease

Schwarz, S. T., Rittman, T., Gontu, V. K., Morgan, P. S., Bajaj, N. P. S., & Auer, D. P. (2011) · Movement Disorders · doi:10.1002/mds.23722 · Cited by 186 · see citing works

PUMA binding induces partial unfolding within BCL-xL to disrupt p53 binding and promote apoptosis

Follis, A. V., Chipuk, J. E., Fisher, J. C., Yun, M., Grace, C. R., Nourse, A., Baran, K., Ou, L., Min, L., White, S. W., et al. (2013) · Nature Chemical Biology · doi:10.1038/nchembio.1166 · Cited by 174 · see citing works

Stage‐dependent nigral neuronal loss in incidental Lewy body and Parkinson's disease

Dijkstra, A. A., Voorn, P., Berendse, H. W., Groenewegen, H. J., Bank, N. B., Rozemüller, A. J. M., & van de Berg, W. D. J. (2014) · Movement Disorders · doi:10.1002/mds.25952 · Cited by 173 · see citing works

Is Bax a mitochondrial mediator in apoptotic death of dopaminergic neurons in Parkinson's disease?

Hartmann, A., Michel, P. P., Troadec, J., Prigent, A., Faucheux, B. A., Ruberg, M., Agid, Y., & Hirsch, É. C. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00160.x · Cited by 153 · see citing works

[The tropical localization and content of noradrenalin and dopamine (3-hydroxytyramine) in the substantia nigra of normal persons and patients with Parkinson's disease].

Hornykiewicz, O. (1963) · PubMed · Cited by 148 · see citing works

Quercetin regulates the sestrin 2-AMPK-p38 MAPK signaling pathway and induces apoptosis by increasing the generation of intracellular ROS in a p53-independent manner

Kim, G. T., Lee, S. H., Kim, J., & Kim, Y. M. (2014) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2014.1658 · Cited by 146 · see citing works

6‐Hydroxydopamine activates the mitochondrial apoptosis pathway through p38 MAPK‐mediated, p53‐independent activation of Bax and PUMA

Gómez-Lázaro, M., Galindo, M. F., Concannon, C. G., Segura, M. F., Fernández-Gómez, F.-J., Llecha, N., Comella, J. X., Prehn, J. H. M., & Jordán, J. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05115.x · Cited by 141 · see citing works

Dopamine Neurons from Transgenic Mice with a Knockout of the p53 Gene Resist MPTP Neurotoxicity

Trimmer, P. A., Smith, T. S., Jung, A. B., et al. (1996) · Neurodegeneration · doi:10.1006/neur.1996.0031 · Cited by 134 · see citing works

Selective Activation of p38 Mitogen-Activated Protein Kinase in Dopaminergic Neurons of Substantia Nigra Leads to Nuclear Translocation of p53 in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Treated Mice

Karunakaran, S., Saeed, U., Mishra, M., Valli, R. K., Joshi, S. D., Meka, D. P., Seth, P., & Ravindranath, V. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.4511-08.2008 · Cited by 134 · see citing works

Optic atrophy 1 mediates mitochondria remodeling and dopaminergic neurodegeneration linked to complex I deficiency

Ramonet, D., Perier, C., Recasens, A., Dehay, B., Bové, J., Costa, V., Scorrano, L., & Vila, M. (2012) · Cell Death and Differentiation · doi:10.1038/cdd.2012.95 · Cited by 104 · see citing works

NADPH Oxidase 1 Mediates α-Synucleinopathy in Parkinson's Disease

Cristóvão, A. C., Guhathakurta, S., Bok, E., Je, G., Yoo, S. D., Choi, D., & Kim, Y. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.2246-12.2012 · Cited by 99 · see citing works

MMP-3 Contributes to Nigrostriatal Dopaminergic Neuronal Loss, BBB Damage, and Neuroinflammation in an MPTP Mouse Model of Parkinson’s Disease

Chung, Y. C., Kim, Y.-S., Bok, E., Yune, T. Y., Maeng, S., & Jin, B. K. (2013) · Mediators of Inflammation · doi:10.1155/2013/370526 · Cited by 94 · see citing works

Management of Parkinson׳s disease: Current and future pharmacotherapy

Kakkar, A. K., & Dahiya, N. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.01.030 · Cited by 92 · see citing works

Paeoniflorin inhibition of 6-hydroxydopamine-induced apoptosis in PC12 cells via suppressing reactive oxygen species-mediated PKCδ/NF-κB pathway

Dong, H., Li, R., Yu, C., Xu, T., Zhang, X., & Dong, M. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.11.008 · Cited by 92 · see citing works

Estrogen and the development and protection of nigrostriatal dopaminergic neurons: Concerted action of a multitude of signals, protective molecules, and growth factors

Kipp, M., Karakaya, S., Pawlak, J., de Araújo, G. W., Arnold, S., & Beyer, C. (2006) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2006.07.001 · Cited by 87 · see citing works

The Oxidation States of DJ-1 Dictate the Cell Fate in Response to Oxidative Stress Triggered by 4-HPR: Autophagy or Apoptosis?

Cao, J., Ying, M., Xie, N., Lin, G., Dong, R., Zhang, J., Yan, H., Yang, X., He, Q., & Yang, B. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5446 · Cited by 86 · see citing works

β‐Ecdysterone Suppresses Interleukin‐1β‐Induced Apoptosis and Inflammation in Rat Chondrocytes via Inhibition of <scp>NF‐κB</scp> Signaling Pathway

Zhang, X., Xu, X., Xu, T., & Qin, S. (2014) · Drug Development Research · doi:10.1002/ddr.21170 · Cited by 83 · see citing works

Ser46 phosphorylation and prolyl-isomerase Pin1-mediated isomerization of p53 are key events in p53-dependent apoptosis induced by mutant huntingtin

Grison, A., Mantovani, F., Comel, A., Agostoni, E., Gustincich, S., Persichetti, F., & Sal, G. D. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106198108 · Cited by 79 · see citing works

Blocking c-Jun N-terminal Kinase (JNK) Translocation to the Mitochondria Prevents 6-Hydroxydopamine-induced Toxicity in Vitro and in Vivo

Chambers, J. W., Howard, S., & LoGrasso, P. V. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.421354 · Cited by 72 · see citing works

Apoptosis in Parkinson's disease: Is p53 the missing link between genetic and sporadic Parkinsonism?

da Costa, C. A., & Checler, F. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2010.10.020 · Cited by 71 · see citing works

Inhibition of Rho kinase mediates the neuroprotective effects of estrogen in the MPTP model of Parkinson's disease

Rodriguez-Perez, A. I., Dominguez‐Meijide, A., Lanciego, J. L., Guerra, M. J., & Labandeira-García, J. L. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.06.004 · Cited by 69 · see citing works

Genetic assessment of familial and early‐onset Parkinson's disease in a Greek population

Bozi, M., Papadimitriou, D. A., Antonellou, R., et al. (2013) · European Journal of Neurology · doi:10.1111/ene.12315 · Cited by 66 · see citing works

p38MAPK/p53-Mediated Bax induction contributes to neurons degeneration in rotenone-induced cellular and rat models of Parkinson’s disease

Wu, F., Wang, Z., Gu, J., et al. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2013.05.006 · Cited by 60 · see citing works

CDK5-mediated phosphorylation and autophagy of RKIP regulate neuronal death in Parkinson's disease

Zheng, W., Shu, Y., Gao, C., Wang, X., Qi, G., Zhang, P., Li, M., Shi, J., & Tian, B. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.05.034 · Cited by 60 · see citing works

p38MAPK and ERK1/2 dictate cell death/survival response to different pro-oxidant stimuli via p53 and Nrf2 in neuroblastoma cells SH-SY5Y

Filomeni, G., Piccirillo, S., Rotilio, G., & Ciriolo, M. R. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.02.003 · Cited by 58 · see citing works

Pivotal roles of p53 transcription-dependent and -independent pathways in manganese-induced mitochondrial dysfunction and neuronal apoptosis

Wan, C., Ma, X., Shi, S., Zhao, J., Nie, X., Han, J., Xiao, J., Wang, X., Jiang, S., & Jiang, J. (2014) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2014.10.013 · Cited by 51 · see citing works

Traditional Chinese medicine for Parkinson??s disease: a review of Chinese literature

Li, Q., Zhao, D., & Bézard, E. (2006) · Behavioural Pharmacology · doi:10.1097/00008877-200609000-00006 · Cited by 49 · see citing works

Connecting Phenotype and Chemotype: High-Content Discovery Strategies for Natural Products Research

Kurita, K. L., & Linington, R. G. (2015) · Journal of Natural Products · doi:10.1021/acs.jnatprod.5b00017 · Cited by 39 · see citing works

Therapeutic strategies in Parkinson's disease: what we have learned from animal models

Valadas, J. S., Vos, M. H., & Verstreken, P. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12577 · Cited by 38 · see citing works

The Parkinson's Disease-Related Protein DJ-1 Protects Dopaminergic Neurons in vivo and Cultured Cells from Alpha-Synuclein and 6-Hydroxydopamine Toxicity

Batelli, S., Invernizzi, R. W., Negro, A., Calcagno, E., Rodilossi, S., Forloni, G., & Albani, D. (2014) · Neurodegenerative Diseases · doi:10.1159/000367993 · Cited by 36 · see citing works

Phytoestrogen β-Ecdysterone Protects PC12 Cells Against MPP⁺-Induced Neurotoxicity<i>In Vitro</i>: Involvement of PI3K-Nrf2-Regulated Pathway

Zou, Y., Wang, R., Guo, H., & Dong, M. (2015) · Toxicological Sciences · doi:10.1093/toxsci/kfv111 · Cited by 36 · see citing works

Docosahexaenoic acid prevents paraquat-induced reactive oxygen species production in dopaminergic neurons via enhancement of glutathione homeostasis

Lee, H. J., Han, J., Jang, Y., Kim, S., Park, J. H., Seo, K. S., Jeong, S., Shin, S., Lim, K., Heo, J. Y., et al. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.12.085 · Cited by 31 · see citing works

The protein l-isoaspartyl (d-aspartyl) methyltransferase protects against dopamine-induced apoptosis in neuroblastoma SH-SY5Y cells

Ouazia, D., Levros, L.-C., Rassart, É., et al. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.03.026 · Cited by 30 · see citing works

Anti-oxidation and Antiapoptotic Effects of Chondroitin Sulfate on 6-Hydroxydopamine-Induced Injury Through the Up-Regulation of Nrf2 and Inhibition of Mitochondria-Mediated Pathway

Ju, C., Hou, L., Sun, F., Zhang, L., Zhang, Z., Gao, H., Wang, L., Wang, D., Lv, Y., & Zhao, X. (2015) · Neurochemical Research · doi:10.1007/s11064-015-1628-8 · Cited by 23 · see citing works

Characterization of Puma-Dependent and Puma-Independent Neuronal Cell Death Pathways following Prolonged Proteasomal Inhibition

Tuffy, L. P., Concannon, C. G., D’Orsi, B., King, M. A., Woods, I., Huber, H. J., Ward, M. W., & Prehn, J. H. M. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00575-10 · Cited by 18 · see citing works

Dopamine down-regulation of protein L-isoaspartyl methyltransferase is dependent on reactive oxygen species in SH-SY5Y cells

Ouazia, D., Levros, L.-C., Rassart, É., et al. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.03.001 · Cited by 15 · see citing works

Homocysteine Intracerebroventricular Injection Induces Apoptosis in the Substantia Nigra Cells and Parkinson's Disease LikeBehavior in Rats.

Ataie, A., Ataee, R., Mansoury, Z., et al. (2013) · PubMed · Cited by 12 · see citing works

Dopamine Replacement Therapy and Deep Brain Stimulation of the Subthalamic Nuclei Induce Modulation of Emotional Processes at Different Spatial Frequencies in Parkinson's Disease

Mermillod, M., Mondillon, L., Rieu, I., Devaux, D., Chambres, P., Auxiette, C., Dalens, H., Coulangeon, L. M., Jalenques, I., & Durif, F. (2014) · Journal of Parkinson s Disease · doi:10.3233/jpd-130256 · Cited by 12 · see citing works

Stimulation of electron transport as potential novel therapy in Parkinson's disease with mitochondrial dysfunction

Vos, M. H., Verstreken, P., & Klein, C. (2015) · Biochemical Society Transactions · doi:10.1042/bst20140325 · Cited by 10 · see citing works

An Alternative Medical Approach for the Neuroprotective Therapy to Slow the Progression of Parkinson's Disease

Muroyama, A. (2013) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.13-00158 · Cited by 7 · see citing works

β-Ecdysterone Protects SH-SY5Y Cells against β-Amyloid-Induced Apoptosis via c-Jun N-Terminal Kinase- and Akt-Associated Complementary Pathways

Xu, T., Niu, C., Zhang, X., & Dong, M. (2018) · Laboratory Investigation · doi:10.1038/s41374-017-0009-0 · Cited by 58 · see citing works

Steroid-ENRICHED FRAction of Achyranthes bidentata protects Amyloid β peptide 1–40-induced cognitive dysfunction and neuroinflammation in rats

Lin, L.-W., Tsai, F.-H., Lan, W.-C., Cheng, Y.-D., Lee, S.-C., & Wu, C.-R. (2019) · Molecular Neurobiology · doi:10.1007/s12035-018-1436-7 · Cited by 31 · see citing works

The insect molting hormone 20-hydroxyecdysone protects dopaminergic neurons against MPTP-induced neurotoxicity in a mouse model of Parkinson’s disease

Lim, H.-S., Moon, B. C., Lee, J., Choi, G., & Park, G. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.07.010 · Cited by 30 · see citing works

Ecdysterone prevents negative effect of acute immobilization stress on energy metabolism of rat liver mitochondria

Baev, A. Y., Charishnikova, O. S., Khasanov, F. A., Nebesnaya, K. S., Makhmudov, A. R., Rakhmedova, M. T., Khushbaktova, Z. A., Syrov, V. N., & Levitskaya, Y. V. (2022) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2022.106066 · Cited by 16 · see citing works

β‑ecdysterone promotes autophagy and inhibits apoptosis in osteoporotic rats

Tang, Y., Yue, Z., Xin, D., Zeng, L., Xiong, Z., Hu, Z., & Xu, C. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.8053 · Cited by 17 · see citing works

Molecular Targets of 20-Hydroxyecdysone in Mammals, Mechanism of Action: Is It a Calorie Restriction Mimetic and Anti-Aging Compound?

Zádor, E. (2025) · Cells · doi:10.3390/cells14060431 · Cited by 9 · see citing works

Ecdysterone Accelerates Healing of Radiation-Induced Oral Mucositis in Rats by Increasing Matrix Cell Proliferation

Li, Y., Ailing, H., & Jian, P. (2019) · Radiation Research · doi:10.1667/rr15171.1 · Cited by 5 · see citing works

Investigation of the antioxidant activity of hesperidin against 6-hydroxydopamine-induced cell damage in SH-SY5Y cells

Jahanshahi, M., Elyasi, L., Ghazvini, H., et al. (2018) · National Journal of Physiology Pharmacy and Pharmacology · doi:10.5455/njppp.2018.8.1249105022018 · Cited by 2 · see citing works

Fucoidan attenuates 6-hydroxydopamine-induced neurotoxicity by exerting anti-oxidative and anti-apoptotic actions in SH-SY5Y cells

Kim, M.-H., Namgoong, H., Jung, B.-D., et al. (2017) · Korean Journal of Veterinary Research · doi:10.14405/kjvr.2017.57.1.1 · Cited by 7 · see citing works

Baicalein attenuates 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y cells

Lee, H. J., Noh, Y. H., Lee, D., Kim, Y. S., Kim, K. Y., Chung, Y. H., Lee, W. B., & Kim, S. S. (2005) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2005.07.003 · Cited by 88 · see citing works

Neuroprotective effects of resveratrol on 6-hydroxydopamine-induced damage of SH-SY5Y cell line

Chang, G.-C., Kim, H., & Wie, M. (2014) · Korean Journal of Veterinary Research · doi:10.14405/kjvr.2014.54.1.1

Carnosic acid protects SH-SY5Y neuronal cells against 6-hydroxydopamine induced cell apoptosis through up-regulation of OPA1

陳玟均, & 蔡佳文 (2014)